Description
- VIP (2mg) / BPC-157 (500mcg) x 30 Tablets is a peptide formulation studied for its potential dual effects on cellular repair and immune modulation.
- Vasoactive Intestinal Peptide (VIP) is investigated in research settings for its anti-inflammatory properties and regulatory role in immune system signaling pathways.
- BPC-157, a stable gastric peptide, has been studied for its influence on tissue regeneration, angiogenesis, and gastrointestinal system homeostasis.
- Researchers have explored the combined use of VIP and BPC-157 to assess their possible synergistic effects on neuroinflammation, mucosal lining protection, and recovery of vascular integrity.
- This combination is commonly evaluated in lab studies focused on chronic inflammatory models, intestinal permeability, and central nervous system disorders.
